MitraClip pioneer Ferolyn Powell dies in motorbike accident
This article was originally published in Clinica
Executive Summary
Ferolyn Powell, best known for leading MitraClip developer Evalve, has died in a motorbike accident while on holiday in Thailand. Ms Powell oversaw the development and commercialization of the transcatheter mitral valve repair device, used to minimally-invasively treat mitral valve regurgitation. Evalve, founded in 1999, was acquired by Abbott in in 2009 for $320m upfront and up to $90m in milestones. Ms Powell then joined Abbott as divisional vice-president and general manager of its newly-formed structural heart unit; MitraClip was approved by the US FDA in October 2013. It remains the only minimally-invasive therapy for mitral regurgitation in the US.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.